Compounds > fura-2
Page last updated: 2024-08-24

fura-2 and rolipram

fura-2 has been researched along with rolipram in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (60.00)18.2507
2000's2 (40.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Botana, LM; MacGlashan, DW1
Berto, L; Cortijo, J; Morcillo, EJ; Navarrete, C; Perpiñá, M; Sanz, C; Villagrasa, V1
Anderson, R; Feldman, C; Goolam Mahomed, A; Ramafi, G; Theron, AJ1
Botana, LM; de la Rosa, LA; Vieytes, MR; Vilariño, N1
Campos-Toimil, M; Keravis, T; Lugnier, C; Orallo, F; Takeda, K1

Other Studies

5 other study(ies) available for fura-2 and rolipram

ArticleYear
Differential effects of cAMP-elevating drugs on stimulus-induced cytosolic calcium changes in human basophils.
    Journal of leukocyte biology, 1994, Volume: 55, Issue:6

    Topics: 1-Methyl-3-isobutylxanthine; Anti-Inflammatory Agents, Non-Steroidal; Basophils; Calcium; Colforsin; Cyclic AMP; Cytosol; Fluorescent Dyes; Fura-2; Histamine Release; Humans; Immunoglobulin E; In Vitro Techniques; Kinetics; Leukotrienes; Microscopy, Fluorescence; N-Formylmethionine Leucyl-Phenylalanine; Pyrrolidinones; Rolipram; Time Factors

1994
Inhibition of phosphodiesterase IV and intracellular calcium levels in human polymorphonuclear leukocytes.
    Methods and findings in experimental and clinical pharmacology, 1996, Volume: 18, Issue:4

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Calcium; Cardiotonic Agents; Cell Survival; Chemotaxis; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 4; Fura-2; Humans; Imidazoles; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Parasympatholytics; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Pyrazines; Pyrrolidinones; Rolipram; Thimerosal

1996
Effect of rolipram and dibutyryl cyclic AMP on resequestration of cytosolic calcium in FMLP-activated human neutrophils.
    British journal of pharmacology, 1998, Volume: 124, Issue:3

    Topics: Adrenergic beta-Agonists; Adult; Albuterol; Bucladesine; Calcium; Calcium Radioisotopes; Cytosol; Fluorescent Dyes; Fura-2; Humans; In Vitro Techniques; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Phosphodiesterase Inhibitors; Pyrrolidinones; Rolipram; Superoxides; Theophylline

1998
Modulation of thapsigargin-induced calcium mobilisation by cyclic AMP-elevating agents in human lymphocytes is insensitive to the action of the protein kinase A inhibitor H-89.
    Cellular signalling, 2001, Volume: 13, Issue:6

    Topics: Adenosine Triphosphatases; Bucladesine; Calcium; Colforsin; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Cytosol; Enzyme Inhibitors; Fluorescent Dyes; Fura-2; Humans; Isoquinolines; Lymphocytes; Microscopy, Fluorescence; Milrinone; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Rolipram; Sulfonamides; Thapsigargin; Time Factors

2001
Short-term or long-term treatments with a phosphodiesterase-4 (PDE4) inhibitor result in opposing agonist-induced Ca(2+) responses in endothelial cells.
    British journal of pharmacology, 2008, Volume: 154, Issue:1

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Blotting, Northern; Blotting, Western; Bucladesine; Calcium; Calcium Signaling; Cell Line; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 4; Cycloheximide; Data Interpretation, Statistical; Endothelial Cells; Fluorescent Dyes; Fura-2; Histamine; Humans; Phosphodiesterase 4 Inhibitors; Phosphodiesterase Inhibitors; Protein Synthesis Inhibitors; Rolipram

2008